Evogene (Israel) Analysis

Evogene Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.93. Some equities with similar Price to Book (P/B) outperform the market in the long run. Evogene recorded a loss per share of 0.72. The entity had not issued any dividends in recent years. The firm had 10:1 split on the 28th of July 2024. Evogene Ltd., together with its subsidiaries, operates as a computational biology company. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. EVOGENE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 131 people. To learn more about Evogene call Ofer CPA at (972) 8 946 6724 or check out www.evogene.com.

Evogene Investment Alerts

Evogene Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 121.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Evogene's market, we take the total number of its shares issued and multiply it by Evogene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 28th of November, Evogene shows the Mean Deviation of 3.12, standard deviation of 4.68, and Variance of 21.88. Evogene technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Evogene Price Movement Analysis

Evogene Outstanding Bonds

Evogene Predictive Daily Indicators

Evogene Forecast Models

Evogene's time-series forecasting models are one of many Evogene's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Evogene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Evogene prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Evogene shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Evogene. By using and applying Evogene Stock analysis, traders can create a robust methodology for identifying Evogene entry and exit points for their positions.

When running Evogene's price analysis, check to measure Evogene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evogene is operating at the current time. Most of Evogene's value examination focuses on studying past and present price action to predict the probability of Evogene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evogene's price. Additionally, you may evaluate how the addition of Evogene to your portfolios can decrease your overall portfolio volatility.